|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/115 | (2010.01) |
| C12N 15/11 | (2006.01) | ||
| A61K 31/7115 | (2006.01) |
| (11) | Number of the document | 3478843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17740201.3 |
| Date of filing the European patent application | 2017-06-30 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/040299 |
| Date | 2017-06-30 |
| (87) | Number | WO 2018/005974 |
| Date | 2018-01-04 |
| (30) | Number | Date | Country code |
| 201662357623 P | 2016-07-01 | US | |
| 201662437592 P | 2016-12-21 | US |
| (72) |
CARTER, Jeff , US
GAWANDE, Bharat , US
JANJIC, Nebojsa , US
SCHNEIDER, Daniel , US
|
| (73) |
Somalogic, Inc. ,
2945 Wilderness Place, Boulder, CO 80301,
US
|
| (54) | OLIGONUCLEOTIDES COMPRISING MODIFIED NUCLEOSIDES |
| OLIGONUCLEOTIDES COMPRISING MODIFIED NUCLEOSIDES |